At present, carcinoembryonic antigen (CEA) and cancer antigen 15–3 (CA15–3) are the most widely used serum tumor markers for the detection and assessment of treatment responses in breast cancer [14]. The gene discussed is CEACAM5; the disease is breast carcinoma.